HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norimasa Miura Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2014Hsa-miR-520d induces hepatoma cells to form normal liver tissues via a stemness-mediated process.
6/2012Biomarkers for hepatocellular carcinoma.
6/2012Erratum to: Biomarkers for hepatocellular carcinoma.
5/2010A novel biomarker TERTmRNA is applicable for early detection of hepatoma.
2/2009A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT.
6/2008Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.
1/2007Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
12/2006Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
5/2005Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norimasa Miura Research Topics

Disease

14Neoplasms (Cancer)
10/2017 - 03/2002
9Hepatocellular Carcinoma (Hepatoma)
01/2014 - 05/2005
3Fatty Liver
03/2016 - 01/2011
3Hypercholesterolemia
03/2016 - 01/2011
3Neoplasm Metastasis (Metastasis)
10/2015 - 12/2006
2Disease Progression
10/2015 - 10/2010
2Lung Neoplasms (Lung Cancer)
06/2008 - 12/2006
2Liver Diseases (Liver Disease)
01/2007 - 05/2005
1Constipation
06/2016
1Non-alcoholic Fatty Liver Disease
03/2016
1Breast Neoplasms (Breast Cancer)
01/2016
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2016
1Leukemia
01/2016
1Tobacco Use Disorder (Nicotine Dependence)
06/2015
1Stomach Ulcer (Gastric Ulcer)
03/2011
1Ulcer
03/2011
1Body Weight (Weight, Body)
01/2011
1Cytokine Release Syndrome
10/2010
1Esophageal Neoplasms (Esophageal Cancer)
10/2010
1Hyperlipidemias (Hyperlipidemia)
06/2009
1Liver Failure
06/2008
1Massive Hepatic Necrosis
06/2008
1Hepatitis
06/2008
1Uterine Neoplasms (Uterine Cancer)
03/2007
1Stomach Neoplasms (Stomach Cancer)
03/2007
1Ovarian Neoplasms (Ovarian Cancer)
03/2007
1Cardiac Arrhythmias (Arrythmia)
08/2005
1Liver Cirrhosis (Hepatic Cirrhosis)
05/2005
1Chronic Hepatitis (Chronic Active Hepatitis)
05/2005
1Arteritis
04/2004
1Carcinogenesis
03/2002
1Hemorrhage
03/2002
1Aberrant Crypt Foci
03/2002
1Colonic Neoplasms (Colon Cancer)
03/2002

Drug/Important Bio-Agent (IBA)

12Messenger RNA (mRNA)IBA
10/2015 - 05/2005
8Telomerase (Telomerase Reverse Transcriptase)IBA
10/2015 - 05/2005
8Biomarkers (Surrogate Marker)IBA
06/2012 - 12/2006
6Tumor Biomarkers (Tumor Markers)IBA
06/2008 - 05/2005
4CholesterolIBA
03/2016 - 06/2009
4MicroRNAs (MicroRNA)IBA
12/2014 - 02/2009
3ErbB Receptors (EGF Receptor)IBA
06/2008 - 12/2006
2atelocollagenIBA
10/2017 - 01/2016
2Ezetimibe (Zetia)FDA Link
03/2016 - 12/2014
2boiogitoIBA
03/2016 - 12/2014
2HesperidinIBA
03/2016 - 01/2011
2Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2016
2Fatty Acid Binding Protein 3IBA
01/2011 - 06/2009
1Ranitidine (Zantac)FDA LinkGeneric
06/2016
1Histamine (Histamine Dihydrochloride)FDA Link
06/2016
1Therapeutic UsesIBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
01/2016
1tyramine-deoxysorbitolIBA
06/2015
1NicotineFDA Link
06/2015
1Cholic AcidIBA
12/2014
1keishibukuryoganIBA
12/2014
1bofu-tsusho-sanIBA
12/2014
1Biocompatible Materials (Biomaterials)IBA
12/2014
1Untranslated RNA (Noncoding RNA)IBA
10/2013
1OligonucleotidesIBA
10/2013
1Dinoprostone (PGE2)FDA Link
03/2011
1shogaolIBA
03/2011
1AcidsIBA
03/2011
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2011
1PowdersIBA
03/2011
1gingerolIBA
03/2011
1CytokinesIBA
03/2011
1Interleukin-6 (Interleukin 6)IBA
10/2010
1Small Interfering RNA (siRNA)IBA
02/2009
1RNA (Ribonucleic Acid)IBA
02/2009
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
06/2008
1Transforming Growth Factor alpha (TGF-alpha)IBA
06/2008
1Proto-Oncogene Proteins c-metIBA
06/2008
1acarboxyprothrombin (PIVKA)IBA
01/2007
1lentil lectinIBA
01/2007
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2007
1TrapidilIBA
08/2005
1SYBR Green IIBA
05/2005
1Pharmaceutical PreparationsIBA
04/2004
1AzoxymethaneIBA
03/2002
1TeaIBA
03/2002
1Sulindac (Copal)FDA LinkGeneric
03/2002
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
03/2002
1Indicators and Reagents (Reagents)IBA
03/2002

Therapy/Procedure

3Therapeutics
10/2010 - 04/2004
2Kampo Medicine (Kampo)
06/2016 - 12/2014
1Perioperative Period
10/2010
1Critical Care (Surgical Intensive Care)
10/2010
1Esophagectomy
10/2010
1Intra-Arterial Infusions
04/2004
1Drug Therapy (Chemotherapy)
04/2004